Suspension de la négociation par l'OCRCVM - LBL Canada NewsWire VANCOUVER, BC, le 7 juin 2021 VANCOUVER, BC, le 7 juin 2021 /CNW/...
IIROC Trading Halt - LBL Canada NewsWire VANCOUVER, BC, June 7, 2021 VANCOUVER, BC, June 7, 2021 /CNW/ - The following issues have been halted by...
Lattice Biologics Ltd. (TSX-V: LBL) (OTCBB: LBLTF) (“Lattice Biologics” or the “Company”) announces that Mr. Donald McInnes has resigned as a...
Lattice Biologics Ltd. (TSX-V: LBL) (OTCBB: LBLTF) (“Lattice Biologics” or the “Company”) is pleased to announce that it has entered into a...
Lattice Biologics Ltd. (TSX-V: LBL) (OTCQB: LBLTF) (“Lattice Biologics” or the “Company”) today announced that it plans to evaluate its amniotic...
Lattice Biologics Ltd. (TSX-V: LBL) (OTCBB: LBLTF) (“Lattice Biologics” or the “Company”) announces financial results for Q2 2019...
Lattice Biologics Ltd. (TSX-V: LBL) (OTCBB: LBLTF) (“Lattice Biologics” or the “Company”) announces the Company has successfully filed all...
Gross Margins Increase to 66% Q1 2018 from 37% Q1 2017 Lattice Biologics Ltd. (TSX-V: LBL) (OTCBB: LBLTF) (“Lattice Biologics” or the...
Lattice Biologics Ltd. (TSX-V: LBL) (OTCQB: LBLTF) (“Lattice Biologics” or the “Company”) announces a change in its Board of Directors and...
First profitable quarter of $.02 per share Lattice Biologics Ltd. (TSX-V: LBL) (OTCQB: LBLTF) (“Lattice Biologics” or the “Company”...
Financial results to be released after market on Tuesday, August 29, 2017 The conference call dial-in number in the release dated August...
Financial results to be released after market on Tuesday, August 29, 2017 Lattice Biologics Ltd. (TSX -V: LBL) (OTCQB: LBLTF) (the...
Lattice Biologics Ltd. (TSX-V: LBL) (OTCQB: LBLTF) (“Lattice Biologics” or the “Company”) announces a relocation of its processing...
TORONTO, June 14, 2017 (GLOBE NEWSWIRE) -- Grenville Strategic Royalty Corp. (TSXV:GRC) (“Grenville” or...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.